Table 2. Spearman’s correlation of serum RBP4 with clinical parameters in patients with SCH.
Variables | Without CAD (n = 51) | P value | With CAD (n = 148) | P value |
Age | 0.112 | 0.433 | 0.125 | 0.131 |
BMI | 0.357 | 0.010 | 0.168 | 0.042 |
SBP | 0.019 | 0.896 | 0.089 | 0.282 |
DBP | 0.012 | 0.933 | 0.018 | 0.829 |
TC | 0.039 | 0.788 | 0.250 | 0.002 |
TG | 0.022 | 0.878 | 0.079 | 0.342 |
LDL-C | 0.079 | 0.582 | 0.276 | 0.001 |
HDL-C | −0.095 | 0.506 | 0.014 | 0.863 |
ApoA | 0.001 | 0.999 | −0.048 | 0.561 |
FBG | 0.017 | 0.903 | 0.143 | 0.084 |
ALT | 0.227 | 0.109 | −0.054 | 0.517 |
AST | 0.144 | 0.314 | −0.077 | 0.349 |
Cr | 0.061 | 0.671 | 0.085 | 0.305 |
UA | 0.045 | 0.753 | 0.094 | 0.257 |
SCH, subclinical hypothyroidism; CAD, coronary artery disease; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoA, Apolipoprotein A; FBG, fasting blood glucose; ALT, alanine aminotransferase; AST, aspartate aminotransferase; Cr, creatine; UA, uric acid; RBP4, retinol-binding protein 4.